The content is available as a PDF (163.1 KB).
Electronic supplementary material
11655_2020_3095_MOESM1_ESM.pdf (32.3KB, pdf)
Appendix 1. Recommended Prescriptions of Traditional Chinese Medicine for COVID-19 Cases
11655_2020_3095_MOESM2_ESM.pdf (87.5KB, pdf)
Appendix 2. Recommended Prescriptions of Western Medicine for COVID-19 Cases
Author Contributions
Luo Y, Qing GC, and Zhang H conceived of the design and carried out the study. Qing GC and Zhang H undertook the literature review of historical evidence and wrote the manuscript. Luo Y and Bai Y provided important suggestions and revised the manuscript. Luo Y supervised the study. All authors read and approved the final manuscript.
Conflict of Interest
No conflict is declared.
Footnotes
Supported by the Fundamental Research Funds for the Central Universities (No. 2020CDJYGRH-YJ05), China
References
- 1.Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-75. Accessed April 4, 2020. Available at https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200404-sitrep-75-covid-19.pdf?sfvrsn=99251b2b_2
- 3.National Health Commission of the People’s Republic of China. Update on the novel coronavirus pneumonia outbreak. Accessed April 4, 2020. Available at http://www.nhc.gov.cn/xcs/yqtb/202004/4f4e36d54fc941d48f6ce6554514075e.shtml
- 4.Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26:243–250. doi: 10.1007/s11655-020-3192-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yang Q, Sun QG, Jiang B, Xu HJ, Luo M, Xie P, et al. Retrospective clinical study on treatment of COVID-2019 patients with integrated traditional Chinese and Western medicine. Chin Tradit Herbal Drugs (Chin) 2020:1–5. http://kns.cnki.net/kcms/detail/12.1108.R.20200413.1302.002.html
- 6.The State Council/The People’s Republic of China. Handbook of prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Accessed April 4, 2020. Available at http://www.gov.cn/zhengce/zhengceku/2020-01/23/5471832/files/106d59e45ac948ceb3cb12d400b8053c.pdf
- 7.Song P, Zhao LH, Li XY, Su JS, Jiang ZY, Song B, et al. Interpretation of TCM part in diagnosis and treatment protocol for COVID-19 (trial version 7). J Tradit Chin Med 2020:1–41. http://kns.cnki.net/kcms/detail/11.2167.R.20200325.1623.002.html [DOI] [PubMed]
- 8.Xia WG, An CQ, Zheng CJ, Zhang JX, Huang M, Wang Y, et al. Clinical observation on 34 patients with novel coronavirus pneumonia (COVID-19) treated with integrated traditional Chinese and Western medicine. J Tradit Chin Med (Chin) 2020;61:375–382. [Google Scholar]
- 9.Fu XX, Lin LP, Tan XH. Clinical study on 37 case of COVID-19 treated with integrated traditional Chinese and Western medicine. Tradit Chin Drug Res Clin Pharmacol (Chin) 2020:1–9. http://kns.cnki.net/kcms/detail/44.1308.R.20200319.1644.002.html
- 10.Cui HT, Li YT, Guo LY, Liu XG, Wang LS, Jia JW, et al. Traditional Chinese medicine for treatment of coronavirus disease 2019: a review. Tradit Med Res. 2020;5:65–73. [Google Scholar]
- 11.Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371:987–997. doi: 10.1016/S0140-6736(08)60453-5. [DOI] [PubMed] [Google Scholar]
- 12.Liang QQ, Chen W, Xu H, Wang LL, Huang Y, Shi Y, et al. Explore the Effect of lymphatic system on acute lung injury caused by 2019-nCoV and the potential mechanism of traditional chinese medicine therapy. World Sci Tech Mod Tradit Chin Med (Chin) 2020:1–8. http://kns.cnki.net/kcms/detail/11.5699.R.20200225.1653.002.html
- 13.Sun ML, Yang JM, Sun YP, Su GH. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Chin J Tuberc Respir Dis (Chin) 2020;43:E014. doi: 10.3760/cma.j.issn.1001-0939.2020.0014. [DOI] [PubMed] [Google Scholar]
- 14.Song YL, Yao C, Yao YM, Han H, Zhao XD, Yu KJ, et al. Xuebijing Injection versus placebo for critically III patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med. 2019;47:e735. doi: 10.1097/CCM.0000000000003842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.China Daily. Qiu Haibo: Xuebijing is effective in treating COVID-19. 2020/3/13. Accessed April 4, 2020. Available at http://cn.chinadaily.com.cn/a/202003/13/WS5e6b84f2a3107bb6b57a661d.html
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
11655_2020_3095_MOESM1_ESM.pdf (32.3KB, pdf)
Appendix 1. Recommended Prescriptions of Traditional Chinese Medicine for COVID-19 Cases
11655_2020_3095_MOESM2_ESM.pdf (87.5KB, pdf)
Appendix 2. Recommended Prescriptions of Western Medicine for COVID-19 Cases